-
Mashup Score: 19Interactive online tool, Vision Simulator, highlights vision loss caused by retinal diseases - 7 hour(s) ago
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5ASCRS 2024: An update from ViaLase on its technology for a nonincisional approach to treating glaucoma. - 11 hour(s) ago
Rick Lewis, chief medical officer of ViaLase, describes the company’s nonincisional glaucoma treatment, showing promising safety and efficacy in studies and possibly paving the way for FDA approval.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2Deep learning model for AI: Stopping nascent GA in its tracks - 15 hour(s) ago
Researchers found the model demonstrated “near-perfect” detection capabilities.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5Sean Donahue, MD, PhD, to become president of the American Association for Pediatric Ophthalmology and Strabismus - 20 hour(s) ago
Donahue will serve as president until June 30, 2025, when he will host the AAPOS 2025 annual meeting in Salt Lake City, Utah. He previously had served as vice president since July 2023.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Study: Pediatric eye care deserts are a growing issue - 1 day(s) ago
Researchers examined disparities in service coverage of pediatric ophthalmologists and pediatric optometrists in relation to patient demographics to cast a light on at-risk populations and provide data for future decisions.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Pediatric eye care deserts are a growing issue. Researchers examined disparities in coverage of pediatric ophthalmologists and optometrists compared to patient demographics to cast light on at-risk populations and gain data for future decisions Read More: https://t.co/a3AbEWEjOP https://t.co/TRJJkTDk4b
-
-
Mashup Score: 20Eyenovia provides clinical, scientific update on FDA-approved products Mydcombi and clobetasol propionate ophthalmic suspension - 1 day(s) ago
The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration of the lowest deliverable dose.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4ASCRS 2024: Tackling unconscious gender bias in ophthalmology, industry, and medicine - 1 day(s) ago
Neda Nikpoor, MD, urges audience members to become more empowered in making small but meaningful, evidence-based changes in combating unconscious gender bias.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 19Interactive online tool, Vision Simulator, highlights vision loss caused by retinal diseases - 2 day(s) ago
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2
Researchers found the model demonstrated “near-perfect” detection capabilities.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 54Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410 - 2 day(s) ago
According to the company, OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA gene.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
Interactive online tool, Vision Simulator, highlights vision loss caused by retinal diseases. The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia Read More: https://t.co/Ih7WAyGler https://t.co/tXpcsNyoDA